Treatment modalities of non-Hodgkin lymphoma patients over 65 years of age: A two-center experience.

Guven CetinElif Ece DoganNilay Sengul SamanciMesut AyerTuba OzkanIskender EkinciRabia BagSeda TurgutOmer Uysal

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2019)

We found that we have achieved a complete remission in more than half of our patients (50.8%). Based on this, treatment should aim remission in elderly patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
rheumatoid arthritis
patient reported outcomes
systemic lupus erythematosus